January 16, 2024 C-Path weighs in on key topics to advance Real-World Data and Artificial Intelligence in Rare Diseases Vice President, Cécile Ollivier, serves on a panel of distinguished experts in the EJP RD-EFPIA Joint Advanced Webinar on...
January 11, 2024 C-Path to Lead New Task Force Aimed at Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases Critical Path Institute (C-Path) today announced the launch of a task force focused on accelerating drug...
January 9, 2024 Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes This webinar presents an overview of the published article in the Journal of the Society for Clinical Data Management that...
January 9, 2024 C-Path Appoints Dr. Klaus Romero as New CEO Longtime quantitative medicine and regulatory science expert to spearhead C-Path's collaborative efforts in accelerating...
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective The Critical Path Institute convened the Support Flexible Approaches to PRO Data Collection project as part of the eCOA: Gettin
December 14, 2023 Best Practice Recommendations for Electronic Clinical Outcome Assessment Data Changes
December 12, 2023 eCOA Clinic #1 | Bring Your Own Device (BYOD) Join us for our first eCOA Clinic! This event offers attendees the chance to bring any questions (or comments) you may have...
December 12, 2023 C-Path Welcomes Mucopolysaccharidosis Clinical Trial Data Contribution from Children’s Hospital of Orange County into RDCA-DAP TUCSON, Ariz., December 12, 2023 – C-Path (Critical Path Institute) is thrilled to announce a significant addition to its Rare D
December 12, 2023 C-Path’s RDCA-DAP Program and PicnicHealth Announce Data Collaboration to Accelerate Rare Disease Research TUCSON, Ariz., December 12, 2023 – Critical Path Institute (C-Path), a leader in advancing rare disease research, is pleased to